country

Change Language

EN - English
FR - Français
DE - Deutsch
ES - Español
JA - 日本語
KO - 한국어

Country or Region:

United States

Product Name	Size / Unit Price	Qty

Total: USD 0.00 Checkout

製品番号: HY-119340

Copy Link Print Information

Mitoflaxone

(別名: Flavoneacetic acid)

Mitoflaxone (flavoneacetic acid) is a synthetic flavonoid compound with vascular targeting properties. Mitoflaxone exerts anti-proliferative effects on endothelial cells through a superoxide-dependent mechanism, this effect leads to changes in the permeability of tumor blood vessels, thereby exerting anti-tumor effects^{[1]^{^{[2]^.}}}

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

CAS 番号: 87626-55-9
分子式: C₁₇H₁₂O₄
分子量:280.27

保管条件:

Please store the product under the recommended conditions in the Certificate of Analysis.

Data Sheet (268 KB)

Mitoflaxone 構造式

CAS 番号: 87626-55-9

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

Cellular Effect

Cell Line	Type	Value	Description	References
2008	IC₅₀	421.3 μM Compound: FAA (Flavone -8-acetic acid)	Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells Direct cytotoxicity against the selected tumor cell line 2008 was determined especially on ovarian adenocarcinoma derived cells	[PMID: 12904070]
A549	IC₅₀	341.5 μM Compound: 2, FAA	Cytotoxicity against human A549 cells after 24 hrs by MTT assay Cytotoxicity against human A549 cells after 24 hrs by MTT assay	[PMID: 24518295]
C13	IC₅₀	233.3 μM Compound: FAA (Flavone -8-acetic acid)	Direct cytotoxicity against the selected tumor cell line c13* was determined especially on ovarian adenocarcinoma derived cells Direct cytotoxicity against the selected tumor cell line c13* was determined especially on ovarian adenocarcinoma derived cells	[PMID: 12904070]
DLD-1	IC₅₀	>500 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit DLD1 cells In vitro concentration required to inhibit DLD1 cells	10.1016/0960-894X(94)85031-3
HCT-8	IC₅₀	245 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit HCT18 cells In vitro concentration required to inhibit HCT18 cells	10.1016/0960-894X(94)85031-3
HT-29	IC₅₀	2449.5 μM Compound: 2, FAA	Cytotoxicity against human HT-29 cells after 24 hrs by MTT assay Cytotoxicity against human HT-29 cells after 24 hrs by MTT assay	[PMID: 24518295]
HT-29	IC₅₀	390 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit HT-29 cells In vitro concentration required to inhibit HT-29 cells	10.1016/0960-894X(94)85031-3
K562	IC₅₀	310 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit K562 cells In vitro concentration required to inhibit K562 cells	10.1016/0960-894X(94)85031-3
LoVo	IC₅₀	378.3 μM Compound: FAA (Flavone -8-acetic acid)	In vitro cytotoxicity against the selected tumor cell line LoVoR arising from human colon adenocarcinoma was determined In vitro cytotoxicity against the selected tumor cell line LoVoR arising from human colon adenocarcinoma was determined	[PMID: 12904070]
LoVo	IC₅₀	563.9 μM Compound: FAA (Flavone -8-acetic acid)	In vitro cytotoxicity against the selected tumor cell line LoVoS arising from human colon adenocarcinoma was determined In vitro cytotoxicity against the selected tumor cell line LoVoS arising from human colon adenocarcinoma was determined	[PMID: 12904070]
MAC15A	IC₅₀	150 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit MAC 15 A cells In vitro concentration required to inhibit MAC 15 A cells	10.1016/0960-894X(94)85031-3
MAC16	IC₅₀	180 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit MAC 16 cells In vitro concentration required to inhibit MAC 16 cells	10.1016/0960-894X(94)85031-3
MAC26	IC₅₀	208 μg/mL Compound: 1 (FAA, NSC-347512 LM975)	In vitro concentration required to inhibit MAC 26 cells In vitro concentration required to inhibit MAC 26 cells	10.1016/0960-894X(94)85031-3

化学情報

CAS 番号 87626-55-9
分子量 280.27
分子式 C₁₇H₁₂O₄
SMILES

O=C1C2=C(C(CC(O)=O)=CC=C2)OC(C3=CC=CC=C3)=C1
別名

Flavoneacetic acid
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

Please store the product under the recommended conditions in the Certificate of Analysis.

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (268 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Mitoflaxone. In subject area: Pharmacology, Toxicology and Pharmaceutical Science.

[2]. Yadav RP, et al. Purification and characterization of a regiospecific lipase from Aspergillus terreus. Biotechnology and applied biochemistry. 1998 Dec;28(3):243-9.

Calculators

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Keywords

MOQ

Minimum order quantity

100 mg

お問い合わせ在庫あり

Other size

お問い合わせ